Skip to main content

Table 1 Baseline characteristics of participants according to AWGS-defined sarcopenia

From: Inflammatory indexes are not associated with sarcopenia in Chinese community-dwelling older people: a cross-sectional study

Characteristics No sarcopenia
(n = 323)
Sarcopenia
(n = 61)
p
Women (%) 182 (56.3) 42 (68.9) 0.069
Age (years) 70.7 ± 5.3 75.9 ± 6.5 < 0.001
Comorbidities (%)
 Hypertension 96 (29.7) 20 (32.8) 0.632
 Coronary heart disease 25 (7.7) 11 (18.0) 0.011
 Diabetes 29 (9.0) 7 (11.5) 0.539
 Stoke 41 (12.7) 6 (9.8) 0.532
 COPD 28 (8.7) 4 (6.6) 0.584
 Cognitive impairment 6 (1.9) 8 (13.1) < 0.001
 History of falls 43 (13.3) 16 (26.2) 0.010
BMI (kg/m2) 24.4 ± 3.4 23.4 ± 2.9 0.025
CC (cm) 32.7 ± 2.6 30.8 ± 2.2 < 0.001
ASM (kg) 15.4 ± 3.8 12.3 ± 2.6 < 0.001
ASMI (kg/m2) 6.3 ± 1.0 5.4 ± 0.8 < 0.001
Body fat mass (kg) 19.0 ± 5.8 18.5 ± 5.1 0.531
Gait speed (m/s) 0.9 ± 0.2 0.6 ± 0.1 < 0.001
Handgrip strength (kg) 24.4 ± 8.7 14.8 ± 4.8 < 0.001
Laboratory parameters
 Total bilirubin (μmol/L) 15.2 ± 6.4 15.2 ± 6.3 0.956
 Direct bilirubin (μmol/L) 5.1 ± 1.8 4.9 ± 1.7 0.388
 ALT (IU/L) 19.3 ± 10.2 20.0 ± 17.3 0.623
 AST (IU/L) 23.0 ± 7.0 24.9 ± 13.4 0.115
 Albumin (g/L) 43.1 ± 2.6 42.2 ± 2.9 0.007
 Globulin (g/L) 28.6 ± 4.2 30.2 ± 4.7 0.007
 Alkaline phosphatase (IU/L) 78.7 ± 21.0 81.9 ± 23.7 0.285
 GGT (IU/L) 23.5 ± 15.9 24.3 ± 21.6 0.714
 Creatinine (μmol/L) 74.3 ± 17.8 73.4 ± 20.8 0.732
 Cystatin C (mg/L) 1.0 ± 0.2 1.1 ± 0.2 0.230
 Uric acid (μmol/L) 332.5 ± 82.7 311.0 ± 81.6 0.063
 Glucose (mmol/L) 5.5 ± 1.4 5.6 ± 1.8 0.442
 Triglyceride (mmol/L) 1.5 ± 1.0 1.3 ± 0.7 0.226
 Total cholesterol (mmol/L) 4.5 ± 0.9 4.6 ± 1.0 0.481
 HDL-C (mmol/L) 1.4 ± 0.4 1.6 ± 0.4 0.004
 LDL-C (mmol/L) 2.9 ± 0.8 2.9 ± 0.9 0.955
 CRP (mg/L) 2.7 ± 1.9 2.9 ± 2.0 0.420
 Hemoglobin (g/L) 137.2 ± 15.6 129.2 ± 16.1 < 0.001
 Platelet (10^9/L) 148.8 ± 52.3 157.6 ± 59.7 0.240
 Leukocyte (10^9/L) 5.5 ± 1.4 5.4 ± 1.6 0.488
 Neutrophil (10^9/L) 3.3 ± 1.0 3.2 ± 1.2 0.638
 Lymphocyte (10^9/L) 1.7 ± 0.5 1.6 ± 0.5 0.482
 Monocyte (10^9/L) 0.4 ± 0.2 0.4 ± 0.1 0.406
  1. Notes: Data are presented as the number (percentage) for the following variables: women and specific comorbidities listed above. For other variables, the mean ± SD is applied
  2. One-way ANOVA and chi-squared tests were used where appropriate. P < 0.05 indicates statistically significant
  3. Abbreviations: ALT alanine aminotransferase, ASM appendicular skeletal muscle mass, ASMI appendicular skeletal muscle index, AST aspartate aminotransferase, BMI body mass index, CC calf circumference, COPD chronic obstructive pulmonary disease, CRP C-reactive protein, GGT γ-glutamyl transpeptidase, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol